Using @RISK in Evaluating Full (late stage) Compound Development in the Pharmaceutical Industry
Venkat Raman
VR Advisors LLC
This free live webcast will discuss the financial evaluation of late stage development of compound in the pharmaceutical industry, but the rational, methodology and analysis discussed here has universal applicability to any multi-stage product development activities across industries. We will not discuss the real options analysis here, as this is not the intended objective of this presentation. But the webcast will: